Browse > Article

Metabolic Regulation of Homocysteine in Type 2 Diabetic Goto-Kakizaki Rats  

Oh, Jung-Min (College of Pharmacy and Research Center for Transgenic Cloned Pigs, Chungnam National University)
Yeo, Su-Jeong (College of Pharmacy and Research Center for Transgenic Cloned Pigs, Chungnam National University)
Kim, Bong-Hee (College of Pharmacy and Research Center for Transgenic Cloned Pigs, Chungnam National University)
Kim, Sang-Kyum (College of Pharmacy and Research Center for Transgenic Cloned Pigs, Chungnam National University)
Publication Information
Environmental Analysis Health and Toxicology / v.22, no.2, 2007 , pp. 165-170 More about this Journal
Abstract
Elevation of homocysteine levels is a risk factor for cardiovascular diseases and liver diseases. It has been reported that both streptozotocin-induced type I diabetic rats and obese type II diabetic rats have plasma total homocysteine lower than each control rats. We determined the effects of lean type II diabetes on homocysteine levels using type 2 diabetic Goto-Kakizaki rats. The concentrations of serum glucose were increased to ${\sim}two-fold$ of control levels and the total cholesterol levels were also increased in GK rats. Hepatic aspartate, histidine, threonine, alanine and methionine levels were significantly increased in GK rats. Plasma aspartate and glutamate levels were elevated, but threonine and arginine levels were decreased in GK rats. Plasma total homocysteine levels were not changed in GK rats, but hepatic total homocysteine levels were increased to ${\sim}three-fold$ of control levels. These results suggest that hepatic metabolism of sulfur-amino acid may be altered in diabetic condition.
Keywords
type II diabetes; homocysteine; hepatic metabolism; amino acid;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Fonseca VA, Mudaliar S, Schmidt B, Fink LM, Kern PA and Henry RR. Plasma homocysteine concentrations are regulated by acute hyperinsulinemia in nondiabetic but not type 2 diabetic subjects, Metabolism 1998; 47(6): 686-689   DOI   ScienceOn
2 Hoogeveen EK, Kostense PJ, Jakobs C, Dekker JM, Nijpels G, Heine RJ, Bouter LM and Stehouwer CD. Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes: 5-year follow-up of the Hoorn Study, Circulation 2000; 101(13): 1506-1511   DOI
3 Rodrigo R, Passalacqua W, Araya J, Orellana M and Rivera G. Implications of oxidative stress and homocysteine in the pathophysiology of essential hypertension, J Cardiovasc Pharmacol 2003; 42(4): 453-461   DOI   ScienceOn
4 Schrijvers BF, De Vriese AS, Van de Voorde J, Rasch R, Lameire NH and Flyvbjerg A. Long-term renal changes in the Goto-Kakizaki rat, a model of lean type 2 diabetes, Nephrol Dial Transplant 2004; 19(5): 1092-1097   DOI   ScienceOn
5 Stipanuk MH. Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine, Annu Rev Nutr 2004; 24: 539-577   DOI   ScienceOn
6 Voutilainen S, Morrow JD, Roberts LJ 2nd, Alfthan G, Alho H, Nyyssonen K and Salonen JT. Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels, Arterioscler Thromb Vasc Biol 1999; 19(5): 1263-1266   DOI
7 Witte K, Jacke K, Stahrenberg R, Arlt G, Reitenbach I, Schilling L and Lemmer B. Dysfunction of soluble guanylyl cyclase in aorta and kidney of Goto-Kakizaki rats: influence of age and diabetic state, Nitric Oxide 2002; 6(1): 85-95   DOI   ScienceOn
8 Mato JM and Lu SC. Homocysteine, the bad thiol, Hepatology 2005; 41(5): 976-979   DOI   ScienceOn
9 Wijekoon EP, Hall B, Ratnam S, Brosnan ME, Zeisel SH and Brosnan JT. Homocysteine metabolism in ZDF (type 2) diabetic rats, Diabetes 2005; 54(11): 3245-3251   DOI   ScienceOn
10 Portha B. Programmed disorders of beta-cell development and function as one cause for type 2 diabetes? The GK rat paradigm, Diabetes Metab Res Rev 2005; 21(6): 495 -504   DOI   ScienceOn
11 Kim SK, Seo JM, Jung YS, Kwak HE and Kim YC. Alterations in hepatic metabolism of sulfur-containing amino acids induced by ethanol in rats, Amino Acids 2003; 24(1-2): 103-110
12 van Guldener C and Stehouwer CD. Hyperhomocysteinemia, vascular pathology, and endothelial dysfunction, Semin Thromb Hemost 2000; 26(3): 281-289   DOI   ScienceOn
13 Zhang X, Li H, Jin H, Ebin Z, Brodsky S and Goligorsky MS. Effects of homocysteine on endothelial nitric oxide production, Am J Physiol 2000; 279(4): F671-678
14 Kim SK and Kim YC. Effects of betaine supplementation on hepatic metabolism of sulfur-containing amino acids in mice, J Hepatol 2005; 42(6): 907-913   DOI   ScienceOn
15 Finkelstein JD and Martin JJ. Homocysteine, Int J Biochem Cell Biol 2000; 32(4): 385-389   DOI   ScienceOn
16 Sutton-Tyrrell K, Bostom A, Selhub J and Zeigler-Johnson C. High homocysteine levels are independently related to isolated systolic hypertension in older adults, Circulation 1997; 96(6): 1745-1749   DOI
17 Munshi MN, Stone A, Fink L and Fonseca V. Hyperhomocysteinemia following a methionine load in patients with non-insulin-dependent diabetes mellitus and macrovascular disease, Metabolism 1996; 45(1): 133-135   DOI   ScienceOn
18 Ratnam S, Maclean KN, Jacobs RL, Brosnan ME, Kraus JP and Brosnan JT. Hormonal regulation of cystathionine beta-synthase expression in liver, J Biol Chem 2002; 277(45): 42912-42918   DOI   ScienceOn
19 Finkelstein JD. Pathways and regulation of homocysteine metabolism in mammals, Semin Thromb Hemost 2000; 26(3): 219-225   DOI   ScienceOn
20 Jacobs RL, House JD, Brosnan ME and Brosnan JT. Effects of streptozotocin-induced diabetes and of insulin treatment on homocysteine metabolism in the rat, Diabetes 1998; 47(12): 1967-1970   DOI   ScienceOn
21 Boers GH. Mild hyperhomocysteinemia is an independent risk factor of arterial vascular disease, Semin Thromb Hemost 2000; 26(3): 291-295   DOI   ScienceOn